Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 7 completed trials

    Completion Rate
    100%(7/7)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    2
    29%
    Phase 1
    4
    57%
    Phase 1/2
    1
    14%

    Phase Distribution

    4

    Early Stage

    3

    Mid Stage

    0

    Late Stage

    Phase Distribution7 total trials
    Phase 1Safety & dosage
    4(57.1%)
    Phase 1/2Combined phases
    1(14.3%)
    Phase 2Efficacy & side effects
    2(28.6%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    7 of 7 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    7

    all time

    Status Distribution
    Completed(7)

    Detailed Status

    Completed7

    Development Timeline

    Analytics

    Development Status

    Total Trials
    7
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 14 (57.1%)
    Phase 1/21 (14.3%)
    Phase 22 (28.6%)

    Trials by Status

    completed7100%

    Recent Activity

    0 active trials
    Showing 5 of 7
    completedphase_1

    Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

    NCT00019006
    completedphase_1

    Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

    NCT00006387
    completedphase_2

    Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

    NCT00019084
    completedphase_2

    Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

    NCT00019331
    completedphase_1_2

    Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

    NCT00019591
    View all 7 trials

    Clinical Trials (7)

    Showing 7 of 7 trials
    NCT00019006Phase 1

    Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

    Completed
    NCT00006387Phase 1

    Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

    Completed
    NCT00019084Phase 2

    Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

    Completed
    NCT00019331Phase 2

    Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

    Completed
    NCT00019591Phase 1/2

    Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

    Completed
    NCT00005630Phase 1

    Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

    Completed
    NCT00003959Phase 1

    Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome

    Completed

    All 7 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    7